prilocaine + lidocaine hydrochloride Cream 25 mg + 25 mg/g - 5 g, 30 g
Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Serbia
, Vietnam
, Vietnam
Comments
File status: EU eCTD Hybrid application Q2 2025
Manufacturer #3436
A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.
Manufacturer usually replies in 18 days
None